BIBLIOGRAPHIC RECORD

Effectiveness and safety of repeat dose subcutaneous ketamine for treatment-resistant depression, and the impact of prior ketamine treatment: open label extension of the KADS study.

This record contains bibliographic metadata. Open the linked source to check the work; the record does not include its full text.

Recorded authors
Nick Glozier; Richard Morris; Elizabeth Stratton; Andrew Somogyi; Shanthi Sarma; Anthony Rodgers; Veronica Galvez-Ortiz; Stevan Nikolin; Philip Bowden Mitchell; Natalie T Mills; Donel Martin; Sean D Hood; Dusan Hadzi-Pavlovic; Maree L Hackett; Paul Glue; Vanessa Dong; Mary Lou Chatterton; Gregory Carter; Michael Berk; Adam J Bayes; Bernhard T Baune; David Barton; Angelo Alonzo; Colleen K Loo
Source of metadata
PubMed
Year recorded
2026

Public identifiers and source

Open the source record

Reference

Nick Glozier; Richard Morris; Elizabeth Stratton; Andrew Somogyi; Shanthi Sarma; Anthony Rodgers; Veronica Galvez-Ortiz; Stevan Nikolin; Philip Bowden Mitchell; Natalie T Mills; Donel Martin; Sean D Hood; Dusan Hadzi-Pavlovic; Maree L Hackett; Paul Glue; Vanessa Dong; Mary Lou Chatterton; Gregory Carter; Michael Berk; Adam J Bayes; Bernhard T Baune; David Barton; Angelo Alonzo; Colleen K Loo. (2026). Effectiveness and safety of repeat dose subcutaneous ketamine for treatment-resistant depression, and the impact of prior ketamine treatment: open label extension of the KADS study. https://pubmed.ncbi.nlm.nih.gov/42403004/

Reference assembled from the available metadata. Check and cite the original publication before reusing a claim.

Permanent record URL: https://brain.psiconautica.org/en/documentos/d-52c4cd10015aeb162bb81b11a23f098e/